| Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$12 |
Update - Proposed issue of securities - CMB
|
27 Aug 2025 11:35AM |
$0.360 |
$0.435 |
risen by
20.83%
|
|
| Magnetic Resources NL (MAU) ORDINARY FULLY PAID |
Materials |
$556 |
Notice Under Section 708A(5)(e)
|
27 Aug 2025 11:33AM |
$1.290 |
$1.850 |
risen by
43.41%
|
|
| Magnetic Resources NL (MAU) ORDINARY FULLY PAID |
Materials |
$556 |
Application for quotation of securities - MAU
|
27 Aug 2025 11:29AM |
$1.290 |
$1.850 |
risen by
43.41%
|
|
| Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$12 |
Placement Participant Update
|
27 Aug 2025 11:27AM |
$0.360 |
$0.435 |
risen by
20.83%
|
|
CMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Cambium Bio Limited announces an update to its placement participants.
- Certain institutional and sophisticated investors have been added and removed as placement participants.
- There is no change to the total amount of funds raised or the terms of the placement.
- The update is for transparency and compliance with ASX Listing Rules.
- The announcement does not affect the overall outcome or objectives of the placement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$34 |
Investor Webinar Presentation
|
27 Aug 2025 11:23AM |
$0.400 |
$0.240 |
fallen by
40%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$2,111 |
Investor Presentation, 27 August 2025
|
27 Aug 2025 11:21AM |
$17.930 |
$16.650 |
fallen by
7.14%
|
|
| Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID |
Health Care |
$141 |
Proposed issue of securities - OIL
|
27 Aug 2025 11:19AM |
$0.080 |
$0.135 |
risen by
68.75%
|
|
| Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID |
Health Care |
$141 |
Optiscan Launches Entitlement Offer to Raise $17.75m
|
27 Aug 2025 11:18AM |
$0.080 |
$0.135 |
risen by
68.75%
|
|
OIL - Price-sensitive ASX Announcement
Full Release
Key Points
- Optiscan Imaging Limited is raising approximately $17.75 million via a fully underwritten entitlement offer.
- The offer is a 1-for-3.3 pro-rata accelerated non-renounceable entitlement offer at $0.065 per new share.
- The issue price represents a discount to the last closing price.
- Funds will be used for ongoing operations, global market expansion, regulatory approvals, product development, and commercialization.
- The offer is fully underwritten and supported by cornerstone institutional investors.
- Key dates, eligibility, and participation instructions are provided for shareholders.
- The company’s strategy focuses on advancing its technology in global healthcare markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Savannah Goldfields Limited (SVG) ORDINARY FULLY PAID |
Materials |
$25 |
Proposed issue of securities - SVG
|
27 Aug 2025 11:16AM |
$0.015 |
$0.011 |
fallen by
26.67%
|
|
| Savannah Goldfields Limited (SVG) ORDINARY FULLY PAID |
Materials |
$25 |
Placement to raise $15 million
|
27 Aug 2025 11:16AM |
$0.015 |
$0.011 |
fallen by
26.67%
|
|
SVG - Price-sensitive ASX Announcement
Full Release
Key Points
- Savannah Goldfields Limited (SVG) is raising $15 million through a placement.
- 125 million new shares will be issued at $0.12 per share to institutional and sophisticated investors.
- The placement price represents a discount to recent share prices.
- Funds will be used to advance gold projects, expand mining, exploration, and for working capital.
- The placement consists of two tranches, with the second tranche subject to shareholder approval.
- Board and management intend to participate in the placement, subject to approval.
- The capital raise is expected to support company operations and value creation.
- Announcement date is 29 April 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Capital International Fund (Hedged) Active ETF (L1HI) |
Financials |
$49 |
Quarterly Portfolio Disclosure - June 2025
|
27 Aug 2025 11:13AM |
$5.800 |
$5.460 |
fallen by
5.86%
|
|
| Aureka Limited (AKA) ORDINARY FULLY PAID |
Materials |
$13 |
Unmarketable Parcel Completion
|
27 Aug 2025 11:12AM |
$0.089 |
$0.082 |
fallen by
7.87%
|
|
| L1 Capital International Fund (Managed Fund) (L1IF) |
Financials |
$476 |
Quarterly Portfolio Disclosure - June 2025
|
27 Aug 2025 11:11AM |
$6.850 |
$6.300 |
fallen by
8.03%
|
|
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$194 |
Second Supplementary Bidder's Statement & Deed Poll
|
27 Aug 2025 11:11AM |
$0.290 |
$0.185 |
fallen by
36.21%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- BETR Entertainment Limited (BETR) submitted a Second Supplementary Bidder's Statement relating to its off-market takeover offer for all ordinary shares in Beyond International Limited (BYI) that it does not already own.
- The supplementary statement provides additional information and updates to the initial Bidder's Statement and the First Supplementary Bidder's Statement.
- The document sets out further details on the consideration and terms of the offer, including the offer period, conditions, and the process for accepting the offer.
- BETR has entered into a Deed Poll in favor of BYI shareholders, confirming its obligations under the offer, particularly regarding payment of the consideration for shares accepted.
- The supplementary statement clarifies the rights of BYI shareholders and provides additional disclosures required under the Corporations Act.
- Shareholders are encouraged to read all statements in full and seek their own independent financial or legal advice regarding the offer.
- The supplementary statement also addresses certain regulatory and procedural matters relevant to the offer, including updates on approvals and consents obtained or outstanding.
- This document is intended to be read together with the previous Bidder's Statements to provide complete information regarding the takeover process.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pointsbet Holdings Limited (PBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$330 |
BBT: Second Supplementary Bidder's Statement & Deed Poll
|
27 Aug 2025 11:11AM |
$1.250 |
$0.950 |
fallen by
24%
|
|
PBH - Price-sensitive ASX Announcement
Full Release
Key Points
- BBT Bidco Holdings Pty Ltd (BBT) has made an off-market takeover offer for all PBH shares.
- This is the Second Supplementary Bidder's Statement and includes a Deed Poll.
- The offer price for PBH shares has been increased from previous statements.
- Updated information on tax consequences for PBH shareholders is provided.
- Details regarding the status of competition and regulatory approvals are included.
- The document outlines the terms and conditions of the takeover offer.
- Instructions on how PBH shareholders can accept the offer are provided.
- The supplementary statement updates and supplements the Original and First Supplementary Bidder's Statements.
- The Deed Poll confirms BBT's commitment to honour obligations if the offer becomes unconditional.
- Shareholders are informed of the implications of accepting the offer.
- The document addresses status of conditions precedent as at the date of the statement.
- The statement is intended to ensure PBH shareholders have the latest material information regarding the offer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sigma Healthcare Limited (SIG) ORDINARY FULLY PAID |
Health Care |
$32,553 |
Dividend/Distribution - SIG
|
27 Aug 2025 11:09AM |
$3.045 |
$2.820 |
fallen by
7.39%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$291 |
Appendix 4G and 2025 Corporate Governance Statement
|
27 Aug 2025 11:05AM |
$1.075 |
$0.925 |
fallen by
13.95%
|
|
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$59,495 |
Change of Director's Interest Notice
|
27 Aug 2025 10:59AM |
$215.090 |
$124.230 |
fallen by
42.24%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$3 |
Appendix 4G and Corporate Governance Statement
|
27 Aug 2025 10:57AM |
$0.120 |
$0.032 |
fallen by
73.33%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$3 |
Appendix 4E and Annual Report
|
27 Aug 2025 10:56AM |
$0.120 |
$0.032 |
fallen by
73.33%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Invion Limited is an ASX-listed biotechnology company developing Photosoft™ technology for photodynamic therapy.
- For the year ended 30 June 2023, Invion reported a net loss of $3,521,536.
- Total revenue for the period was $4,477,805, mainly from research and development services.
- Key operational focus was on advancing pre-clinical and clinical programs for Photosoft™ across various indications.
- The company’s principal funding and partnership is with The Cho Group, supporting research and development.
- Significant investment was made in R&D, with ongoing projects in cancer, infectious diseases, and inflammatory conditions.
- No dividend was paid or proposed for the financial year.
- The company maintained adequate cash reserves and has no significant borrowings.
- Invion's board and senior management were unchanged during the reporting period.
- Risks include clinical trial outcomes, regulatory approvals, intellectual property protection, and financial sustainability.
- Corporate governance policies and remuneration information are disclosed in the report.
- Audited financial statements and notes are included for full transparency.
- The report affirms Invion’s commitment to expanding its intellectual property portfolio and progressing toward commercialization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$5,027 |
SEC Forms 4
|
27 Aug 2025 10:56AM |
$46.230 |
$27.790 |
fallen by
39.89%
|
|
| Melbana Energy Limited (MAY) ORDINARY FULLY PAID |
Energy |
$17 |
Application for quotation of securities - MAY
|
27 Aug 2025 10:55AM |
$0.017 |
$0.005 |
fallen by
73.53%
|
|
| Duxton Farms Ltd (DBF) ORDINARY FULLY PAID |
Consumer Staple |
$49 |
Change of Director's Interest Notice
|
27 Aug 2025 10:54AM |
$0.980 |
$0.460 |
fallen by
53.06%
|
|
| Challenger Limited (CGF) ORDINARY FULLY PAID |
Financials |
$7,064 |
Dividend/Distribution - CGFPD
|
27 Aug 2025 10:52AM |
$8.275 |
$10.330 |
risen by
24.83%
|
|
| Challenger Limited (CGF) ORDINARY FULLY PAID |
Financials |
$7,064 |
Dividend/Distribution - CGFPC
|
27 Aug 2025 10:51AM |
$8.275 |
$10.330 |
risen by
24.83%
|
|
Call 1300 880 160
Start a chat
Schedule a call
